Data for: Validity of targeted next generation sequencing in routine care for identifying clinically relevant molecular profiles in non-small cell lung cancer: results of a 2 years experience on 1343 samples

1343 NSCLC patients. Molecular diagnosis, CAST vs NGS. Description of molecular alterations (alterations associations, identifications of new actionable targets) using NGS.